About Index Trending news
Analyze
Pricing
Stemgent

Stemgent

Work at Stemgent? Add yourself to this profile

Stemgent

Stemgent is a leading supplier providing mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services.
Edit Profile
More info

Elsewhere

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Debt financing
$2,700,000
Morgenthaler Ventures, HealthCare Ventures
Venture capital (Series B)
$14,000,000
Morgenthaler Ventures, Frazier Healthcare Partners
Employees

Team size

50+
Locations
Unknown
Help us complete this profile

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Stemgent makes some noise.